MTOR and osteosarcoma: For instance, Adewuyi et al. discovered that the activation of the mTOR pathway is a key mechanism for osteosarcoma cells to evade chemotherapy [4]; Zheng et al. confirmed that the abnormal activation of the PDK1-AKT-mTOR axis could drive the invasive phenotype of osteosarcoma cells [29].